Clinical Trials in Washington

Showing 5921-5940 of 7,241 trials

Effect on Weight Loss of Exenatide Versus Placebo

NCT00375492

This trial is designed to compare the effects of twice-daily exenatide and twice-daily placebo on weight loss. This trial will evaluate overweight and obese subjects with type 2 diabetes who have inadequate glycemic control with metformin, sulfonylurea, or metformin plus a sulfonylurea. Subjects will be treated with exenatide or placebo in addition to their current oral antidiabetes agent regimen and participate in a lifestyle modification program.

Type 2 Diabetes Mellitus

AstraZeneca196 participantsStarted Sep 2006

Peoria, Arizona, United States • Jacksonville, Florida, United States • Orlando, Florida, United States +7 more locations

TERMINATEDPhase 335 miles

Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke

NCT01098981

This is a randomized, placebo-controlled, phase 3 clinical trial to evaluate the efficacy and safety of transcranial ultrasound (US) as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.

Acute Ischemic Stroke

Cerevast Therapeutics, Inc.675 participantsStarted May 2013

Redmond, Washington, United States

Effect on Weight Loss of Exenatide Versus Placebo

Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke

Find Trials by Condition in Washington

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)

Mask Ventilation Before and After Neuromuscular Blockade

TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)

Onsite Versus Referral Models of Primary Care for Substance Abusing Patients

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.

CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness

Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011

Comparison of 4 Influenza Vaccines in Seniors

Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index